New drug appears to be helping lung cancer patients beat survival odds

A group of "unique" patients with advanced lung cancer appear to have won their battle for survival after treatment with a new immunotherapy drug.

On average, only 1% to 4% of people diagnosed with the highly aggressive disease are still alive five years later.